Azintuxizumab (SLAMF7/CRACC/CD319) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-829
Artikelname: Azintuxizumab (SLAMF7/CRACC/CD319) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-829
Hersteller Artikelnummer: 10-829
Alternativnummer: PRS-10-829-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Chimeric,Humanized / SLAMF7/CRACC/CD319 [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: ABBV-383,PR-1471272
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.